T2S Leads BNY Mellon to Expand European Settlement Data Capability

Target2-Securities platform catalyzes bank's ISO 20022 upgrade

tom-cas
Tom Casteleyn, head of product management for custody, cash and FX, BNY Mellon

The standardization provided by Target2-Securities (T2S) has fundamentally changed the way BNY Mellon does business in Europe, says its head of product management for custody, cash and foreign exchange.

Tom Casteleyn tells Inside Reference Data that the bank, which is the world's largest custodian, wouldn't have made the upgrade to its infrastructure that allowed it to support ISO 20022 had it not been for T2S.

T2S is a centralized securities settlement platform for the European Union. Casteleyn

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

A tech revolution in an old-school industry: FX

FX is in a state of transition, as asset managers and financial firms explore modernizing their operating processes. But manual processes persist. MillTechFX’s Eric Huttman makes the case for doubling down on new technology and embracing automation to increase operational efficiency in FX.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here